Google
GALDY — GALDERMA GROUP AG (Healthcare >> Drug Manufacturers - Specialty & Generic)
GALDY FAQ
What is GALDY's ROE?
GALDERMA GROUP AG reports a Return on Equity (ROE) of 7.52%.
What is GALDY's dividend yield?
GALDERMA GROUP AG offers a dividend yield of 0.22%.
What is GALDY's Deepscope Quality Score?
Deepscope rates GALDY's overall financial quality at 46 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy GALDY?
Deepscope's AI Timing Score for GALDY is 67 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does GALDY belong to?
GALDERMA GROUP AG is classified under the Healthcare >> Drug Manufacturers - Specialty & Generic sector on the NYSE exchange.
|
USD 40.41
Price
-0.17
(-0.42%)
Day Change
|
|
|---|
GALDY Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 46) và Thời điểm mua ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
Tỷ lệ ROE tương đối thấp
[-] Tốc độ tăng trưởng ROE dưới mức tiêu chí của chúng tôi.
Lịch sử ROE tương đối thấp
Tốc độ tăng trưởng ROA dưới mức tiêu chí của chúng tôi.
Biên lợi nhuận ròng tương đối thấp.
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi
Lịch sử Biên lợi nhuận ròng tương đối thấp.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt lắm , và khả năng kiếm lợi nhuận Không tốt lắm , ...
| Yếu tố Chất lượng |
|
41% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 40.41 |
| PBV / Sector |
1.16 / 2.76
GREAT
|
| Earning Per Share | 2.61 |
| PE / Sector |
N/A / 23.64
|
| PEG or PE/Growth / Sector |
N/A / 0.13
|
| Average 1M Daily Value |
0.62 M
GREAT
|
| Average 1W Daily Value |
0.65 M
GREAT
|
| Yếu tố Kỹ thuật |
|
28% |
| Sức khỏe tài chính |
|
52% |
| Khả năng kiếm lợi nhuận |
|
58% |
| Lợi tức cho nhà đầu tư |
|
12% |
| Chi tiết đăng ký |
| Analyze Date | 2026-06-06 09:08:37 |
| Symbol | GALDY |
| Name | GALDERMA GROUP AG |
| Sector | Healthcare >> Drug Manufacturers - Specialty & Generic |
| Market | NYSE |
| Listed Shares | 1,172.84 M |
| Par Value | N/A |
| Calculated From | YearEnd |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 9,478.92 / 9,835.56 |
| Tin tức, Dự báo ước tính |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: Zählerweg 10, Zug, Switzerland, 6300
Phone: 41 58 455 85 92
Website: https://www.galderma.com
Employees: 7,676
Sector: Healthcare >> Drug Manufacturers - Specialty & Generic
Description: Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
ME vs SECTOR Healthcare >> Drug Manufacturers - Specialty & Generic
Click a bubble to view stock details · Bubble size represents market capitalization share
